Richard Biedermann

Richard Biedermann


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2022 in Children
Verified
Journal Article
Open access
PDF file
SWSarah Werner
Sarah Werner
CDClaus Doerfel
Claus Doerfel
RBRichard Biedermann
Richard Biedermann
MLMichael Lorenz
Michael Lorenz
MRMarius Rasche
Marius Rasche
DVDaniel Vilser
Daniel Vilser
Acute SARS-CoV-2 infections in children and adolescents are usually mild. However, they can suffer from ongoing symptoms, generally referred to as long COVID. Sleep disorders are one of the most frequent complaints in long COVID although precise data are missing. We assessed the sleep behavior of children and adolescents who presented at our outpatient clinic between January 2021 and May 2022 with the Children’s Sleep Habits Questionnaire (CSHQ-DE). We compared the sleep behavior at three different time points: pre-COVID-19; post-COVID-19 at the initial presentation; and post-COVID-19 at re-presentation. Data from 45 patients were analyzed. Of those, 64% were female and the median age was 10 years (range: 0–18 years). Asymptomatic or mild COVID-19 disease was experienced in 89% of patients; 11% experienced moderate disease. The initial presentation occurred at a median of 20.4 weeks (6 weeks–14 months) after the infection. The CSHQ-DE score increased significantly from pre-COVID-19 (45.82 ± 8.7 points) to post-COVID-19 (49.40 ± 8.3 points; p ≤ 0.01). The score then normalized at re-presentation (46.98 ± 7.8; p = 0.1). The greatest changes were seen in the CSHQ-DE subscale score “daytime sleepiness”. Our data showed that children and adolescents with long COVID often suffer from sleep disturbances. For most children and adolescents, these sleep disorders decreased over time without any further medical intervention aside from a basic sleep consultation.

9 January 2026 in Research Square
Verified
Preprint
Open access
PDF file
NMNadine Mand
Nadine Mand
FKFranziska König
Franziska König
SBSebastian Brenner
Sebastian Brenner
NBNora Bruns
Nora Bruns
CDChristian Dohna-Schwake
Christian Dohna-Schwake
RBRichard Biedermann
Richard Biedermann
Introduction Each year, between 250 and 300 children are listed for organ transplantation in Germany, while approximately 30 children donate organs. Despite identified barriers to pediatric organ donation, comprehensive data on characteristics and clinical management of pediatric deaths in German pediatric intensive care units (PICUs), especially those becoming organ donors remains limited. This study aims to analyze epidemiology of in-PICU deaths and characteristics of pediatric organ donors within a multicenter network of German PICUs. Methods Retrospective analysis of data prospectively collected in 33 PICUs participating in the Pediatric Intensive Care Unit Admission Network (PIA) between May 1, 2023 and July 31, 2025. Patients included were children older than 27 days and younger than 18 years who died during their PICU stay. Results Of 11,095 children recorded, 219 died (overall case-fatality rate: 1.97%). Median age at death was 6 years (IQR, 1– 13). Death occurred after withdrawal (30.1%) or limitation of life-sustaining treatment (20.5%), failed maximal therapy (26.5%) and failed cardiopulmonary resuscitation (12.8%). 21/219 (9.6%) children met neurologic criteria for death (brain death, BD). Of those, 11 families consented to organ donation (conversion rate: 52.4%). Median age of organ donors was 4 years (IQR 1–13). Conclusion This first national analysis shows comparable mortality rates but substantially lower brain death diagnosis rates in German PICUs than in international multicenter studies. This gap might suggest missed opportunities for organ donations. More structured donor identification, enhanced training for BD diagnosis, and development of evidence-based guidelines for pediatric donor management may enhance quality of care and increase pediatric organ donation in Germany.

9 October 2025 in Die Radiologie
Verified
Journal Article
Closed access
PDF file
PKPaul-Christian Krüger
Paul-Christian Krüger
RBRichard Biedermann
Richard Biedermann
HMHans-Joachim Mentzel
Hans-Joachim Mentzel

14 October 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
SWSarah Werner
Sarah Werner
CDClaus Doerfel
Claus Doerfel
RBRichard Biedermann
Richard Biedermann
MLMichael Lorenz
Michael Lorenz
MRMarius Rasche
Marius Rasche
DVDaniel Vilser
Daniel Vilser
Acute SARS-CoV-2 infections in children and adolescents are usually mild. However, they can suffer from ongoing symptoms generally referred as long COVID. Sleep disorders are one of the most frequent complaints in long COVID although precise data are missing. We assessed the sleep behavior of children and adolescents who presented at our outpatient clinic between January 2021 and May 2022 with the Children's Sleep Habits Questionnaire (CSHQ-DE). We compared sleep behavior at three different time points: pre-COVID-19, post-COVID-19 at initial presentation and post-COVID-19 at re-presentation. Data from 45 patients were analyzed. Of those, 64% were female and the median age was 10 years (range 0-18 years). Asymptomatic or mild COVID-19 disease was experienced in 89% of patients, whilst 11% experienced moderate disease. Initial presentation occurred at a median of 20.4 weeks (6 weeks - 14 months) after infection. The CSHQ-DE score increased significantly from pre-COVID-19 (45.82+8.7 points) to post-COVID-19 (49.40+8.3 points; p=<0.01). The score then normalized at re-presentation (46.98+7.8; p=0.1). The greatest changes were seen in the CSHQ-DE subscale score "daytime sleepiness". Our data show that children and adolescents with long COVID often suffer from sleep disturbance. For most children and adolescents these sleep disorders decreased over time without further medical intervention, aside from a basic sleep consultation.

28 May 2026 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
RBRichard Biedermann
Richard Biedermann
MKMelanie Koeplin
Melanie Koeplin
CDClaus Doerfel
Claus Doerfel
NLNatja Liebers
Natja Liebers
LNLars Newman
Lars Newman
HPHans Proquitté
Hans Proquitté
Introduction: When standard intravenous regimens fail, children in the pediatric intensive care unit often face escalating sedative polypharmacy with potential harm; we therefore evaluated inhaled isoflurane as a rescue sedation strategy in mechanically ventilated children with failure of a conventional sedation regimen. Methods: In this single-center retrospective observational study (2017–2020) in a 10-bed tertiary mixed pediatric intensive care unit (medical, neurologic, cardiac and traumatic conditions), isoflurane was delivered via an anesthetic conserving device while concomitant intravenous sedatives were down-titrated to sedation targets assessed by the COMFORT-B score, and cardiovascular support was quantified using the vasoactive-inotropic score. Results: Twenty-one children were analyzed (median age 3.0 years; median Pediatric Index of Mortality 3 score 15.9%); isoflurane was initiated after a median of 3 days of prior sedation and continued for a median of 8 days; the median number of sedative agents decreased from 4 to 3 ( p < 0.001), doses of clonidine, sufentanil, and propofol were significantly reduced, and rescue medication use for breakthrough agitation declined from 100% to 42.9% ( p < 0.001), while vasoactive-inotropic score increased from 6.22 to 9.70 ( p = 0.008); five patients died, and among survivors delirium (87.5%) and withdrawal (44%) were frequent, with most extubated within 24 h after isoflurane cessation. Discussion: Isoflurane can meaningfully reduce sedative burden and agitation-related rescue interventions in difficult-to-sedate children, but the observed increase in vasoactive support and frequent delirium/withdrawal after prolonged use underscore the need for vigilant hemodynamic monitoring and structured down-titration—key considerations for centers contemplating volatile-based rescue sedation.